On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude) to supply its mRNA COVID-19 vaccine as an integral part of Brazil’s 2024 national vaccination campaign against COVID-19.

This contract follows the Brazilian Health Regulatory Agency’s (ANVISA) approval of Moderna’s COVID-19 vaccine in March 2024, which encodes the spike protein of the XBB.1.5 sublineage of SARS-CoV-2 for active immunization for the prevention of COVID-19 in children from six months of age and adults.